SpIntellx Inc., a University of Pittsburgh Endowment spin out, has raised $275,000 in venture funding from undisclosed investors. The company, formerly known as Spatial Pathology Diagnostics, also received a $225,000 grant from the National Science Foundation in March. The funds will be used to develop its HistoMapr-Breast system, a computational guide that seeks to improve the accuracy and efficiency of pathologists.

SpIntellx is a computational and systems pathology company that provides explainable AI guides to pathologists and biopharma companies. Co-founded by a group of pathologists, computer scientists, and biotechnologists in 2017, CEO and Co-Founder Chakra Chennubhotla, Ph.D., leads the campus-wide effort in computational systems pathology at Pitt.

In September 2018, the company raised $400,000 through a combination of debt and seed funding in a round, led by Sewickley’s Newlin Investment Co., which put the company’s pre-money valuation at $1.2 million. The funding was to be used for the website launch.